A product sold in the United States that bears an SPF claim — including an SPF 30 face cream containing tranexamic acid — is regulated as an over-the-counter (OTC) drug by the FDA, not as a cosmetic. This is a critical distinction that affects everything from the manufacturing facility you can use to the label copy you are permitted to print.
Under the FDA's OTC Drug Review framework, sunscreen active ingredients and their maximum permitted concentrations are governed by the OTC Sunscreen Monograph, codified in 21 CFR Part 352 and updated through the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020. A product that uses only monograph-approved UV filters (such as avobenzone up to 3%, homosalate up to 15%, octinoxate up to 7.5%, zinc oxide up to 25%, or titanium dioxide up to 25%) at permitted levels, and that complies with all labeling and testing requirements, does not need pre-market approval from the FDA — it is what regulators call a "monograph-compliant" OTC product. This means you can bring it to market without filing a New Drug Application (NDA), which would take years.
However, "no pre-market approval" does not mean "no requirements." The following are mandatory and enforceable: SPF value substantiation through standardized testing (FDA method or ISO 24444 with demonstrated equivalence); broad-spectrum substantiation through critical wavelength testing; labeling that includes a Drug Facts panel with active ingredients (UV filters and their percentages), directions for use, warnings (including the skin cancer prevention language required by the 2019 Sunscreen Final Rule), and inactive ingredients in INCI order; and manufacture in a facility registered with the FDA as an OTC drug manufacturer and inspected under 21 CFR Part 211 pharmaceutical GMP standards.
Transexamic acid itself, as the brightening active, is not an FDA-regulated drug ingredient in this context — it is treated as an inactive ingredient in the finished OTC drug product. This means it does not trigger additional drug review, but it cannot be called out in the Drug Facts active ingredient section; it appears in the inactive ingredient list.
One mistake first-time founders make is placing an order with a contract manufacturer that holds only cosmetic GMP (ISO 22716) certification and assuming that is sufficient for an SPF product. It is not. If the FDA inspects an SPF product manufactured in a non-pharmaceutical GMP facility, the product is subject to seizure. Always confirm FDA OTC drug facility registration before signing. The AJ Cosmo Labs iOS app surfaces OTC-drug-capable manufacturers separately from cosmetics-only facilities, which removes this risk from the supplier-vetting process.
Ingredients in this answer: Tranexamic Acid · Titanium Dioxide · Homosalate · Avobenzone · Zinc Oxide
Read the full guide on Private Label Tranexamic Acid SPF 30 Face Cream Low MOQ →